Vimarsana
Biggest News Aggregation in the World

Page 5 - Brain Modulation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Brain Modulation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Brain Modulation Today - Breaking & Trending Today

Medtronic's Enrolls 1st Patient in Parkinson's Disease Study - Vimarsana News

Medtronic's Enrolls 1st Patient in Parkinson's Disease Study

Medtronic said the ADAPT-PD study will look at the safety and efficacy of the use of adaptive deep brain stimulation in patients with Parkinson’s Disease.

Medtronic launches adaptive deep brain stimulation trial in Parkinson's patients - Vimarsana News

Medtronic launches adaptive deep brain stimulation trial in Parkinson's patients

Medtronic unveils adaptive deep brain stimulation trial in Parkinson's patients Medtronic unveils adaptive deep brain stimulation trial in Parkinson's patients 15 January 2021 | News The randomised study will take place across 12 study sites at leading movement disorders research centers in the US, Europe, and Canada Source: medtronic.com Medtronic plc, the global leader in medical technology, announced the first enrolment in ADAPT-PD (Adaptive DBS Algorithm for Personalised Therapy in Parkinson's Disease), its trial evaluating the safety and efficacy of adaptive deep brain...

Medtronic Launches First-of-Its-Kind Adaptive Deep Brain Stimulation (aDBS) Trial in Parkinson's Disease Patients - Vimarsana News

Medtronic Launches First-of-Its-Kind Adaptive Deep Brain Stimulation (aDBS) Trial in Parkinson's Disease Patients

Parkinson's Disease), its trial evaluating the safety and efficacy of adaptive deep brain stimulation (aDBS) in patients with Parkinson's Disease (PD). Adaptive deep brain stimulation is an investigational feature of the Percept™ PC device that could be enabled if approved. The investigational feature used in this study allows for automated adjustment of brain stimulation to provide therapy to manage symptoms of Parkinson's disease based on a patient's clinical state. The randomized study will take place across 12 study sites at leading Movement Disorders research centers in the United S...